Locations:
Search IconSearch
July 29, 2021/Cancer

Virtual Care and Support for Adolescent and Young Adult Cancer Patients

How virtual visits for clinical trials and peer-to-peer support can improve access and care

21-CHP-2079243-Hero-650×450-1

Well before the start of the pandemic, Cleveland Clinic Children’s was leading virtual care and programming for adolescent and young adult (AYA) patients facing a cancer diagnosis. This existing infrastructure enabled a seamless shift and uninterrupted care for thousands of pediatric patients.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Stefanie Thomas, MD, MS, a pediatric oncologist and Director of the Adolescent and Young Adult Oncology Program at Cleveland Clinic Children’s, says there is a need for services in the virtual space to reach more patients, particularly those with rare cancers. Since Dr. Thomas joined the team in 2019, her clinical and research practice has focused on improving care and access for AYA patients at every point in their care journey.

In 2018, she led a study that assessed the rates of clinical trial enrollment in a group of pediatric and AYA cancer patients. Study findings, published in Cancer, suggest that significantly fewer AYA patients were enrolling in cancer clinical trials than children. These findings contradict conventional thinking that attributes trial existence and availability as barriers to participation.

Utilizing virtual visits for clinical trials

Leveraging virtual visits for clinical trials is a valuable tool to reach this patient population, argues Dr. Thomas. She recently presented best practices on this at a 2021 ASPHO Conference, sharing the following tips to maximize the virtual visit:

  • Set an agenda.
  • Have all clinical information beforehand including most recent scans.
  • Ensure there is a platform where you can share your screen to review imaging.
  • Discuss trial options.
  • Go over basic eligibility criteria and what could make the patient not eligible if they were to come in person.
  • Make documentation available as soon as possible for the patient to review.
  • Follow up in person only if AYA wants to enroll.

“We are one of only a few centers in the country offering clinical trials for new, innovative drugs. That means we have patients who come to us from all parts of the country, usually for a very specific trial. It’s essential that the patient and/or their guardian, really understands the goals and eligibility requirements of the trial before they spend time and money traveling to Cleveland,” she says.

Advertisement

A thorough assessment helps providers discuss the trial, understand the patient’s medical history and manage expectations with the patient and family. For patients who have been enrolled in longer-term oral medication-related studies, this format has allowed the team to do virtual check-ins, rather than having them come to the hospital.

Building community

The AYA program has also ventured into peer-to-peer community support through a virtual platform. Pre-pandemic planning for in-person programming transitioned to a virtual model in early 2020. Taylor Buss, MSW, LISW-S, pediatric and AYA Oncology Social Worker, oversees these programs.

She facilitates two virtual cancer chats for teens age 13 to 17 and young adults age 18 to 29, respectively. The latter is open to any young adult diagnosed with cancer and is not limited to patients being treated at Cleveland Clinic Children’s.

“Some patients are more comfortable accessing these chats from the comfort of their bedrooms. Coming into the hospital can be understandably burdensome, even triggering, for some patients.”

At the end of the day, it’s about building a community, says Ms. Buss. The offerings continue to evolve based on direct feedback from patients, she says. For example, they decided to reframe the virtual meet-ups as “cancer chats,” rather than “support groups.” Participants wanted something that felt less like therapy and more like a community, so, they are now hosting events like a virtual game night in partnership with community origanizations.

Advertisement

The final word

In-person care and in-person community are both extremely important and are not going away. But, Dr. Thomas stresses, it’s important to also recognize the value of standardizing virtual options for select patients, even outside of clinical trials and peer-to-peer social support.

“Some patients don’t need to be physically present to receive their care, and we should recognize that and honor their desires, particularly in cases when they may be receiving bad news.”

Dr. Thomas does caution that moving forward, it will be important to consider the inclusion of multidisciplinary care teams for AYA cancer patients can be achieved in the virtual space.

“We need to make sure that the whole care team, including, for example, nurse coordinators, social workers and psychologists, remain integral to the management of care.”

Advertisement

Related Articles

Interactive culinary medicine class
November 11, 2024/Cancer/Innovations
Integrative Oncology Improves Outcomes and Quality of Life

Combining mind, body and lifestyle practices in alignment with conventional cancer treatment

Pregnant woman
November 6, 2024/Cancer/News & Insight
Large Retrospective Study Finds Pregnancy Safe Among Young BRCA Carriers

Pregnancy did not appear to increase the risk of recurrence in patients or complications in their children

Young patient with cancer
October 25, 2024/Cancer/News & Insight
Multidisciplinary Care Model Supports Young People with Cancer

Integrated program addresses growing need for comprehensive cancer care among adolescents, young adults and adults under 50 with early onset cancers

Hurthle cell carcinoma
October 24, 2024/Cancer/News & Insight
Researchers Uncover Clues to Treating Rare Thyroid Cancer

Studies find mTOR inhibitor may play key role in treating Hurthle cell carcinoma

DNA
October 10, 2024/Cancer/Research
Blocking YES1 Protein Resensitizes Triple-Negative Breast Cancer to Treatment

Obstructing key protein allows for increased treatment uptake for taxane chemotherapy

Plan of care meeting
October 4, 2024/Cancer/Radiation Oncology
Five Years of Parallel Prospective Plan of Care Reviews

Radiation oncology department finds weekly plan of care meetings have multiple benefits

Ad